Overview of Metronidazol STADA
Quick Facts
| Property | Description |
|---|---|
| Active ingredient | Metronidazole |
| Form | Tablets, solution for infusion, suppositories, cream, gel, etc. |
| Pharmacological class | Anti-infective agent, Antiprotozoal agent |
| General purpose | Elimination of anaerobic bacteria and protozoal infections |
| Origin | Synthetic chemical (Nitroimidazole derivative) |
Classification, Active Substance, and Identity
Metronidazol STADA is a medication whose identity is defined by its sole active substance, Metronidazole, a synthetic chemical belonging to the nitroimidazole derivative family. This compound is fundamentally classified within the pharmacological class of anti-infective agents and, more specifically, as an antiprotozoal agent. Metronidazole is a selective anti-infective agent used for systemic and topical applications. The formulation is made available in multiple dosage forms, facilitating various administration methods, including film-coated tablets, solution for infusion, suppositories, vaginal ovules, cream, gel, and oral suspension. These different forms permit either systemic treatment throughout the body or targeted topical application, ensuring the single active substance product can be used as medically required.
What is the Role of Metronidazole in Therapeutics?
The primary role of Metronidazole within the anti-infective class is its function as a selective and potent bactericidal agent against specific categories of pathogens. Its general purpose is to eliminate infections caused by anaerobic bacterial infections and certain protozoal infections. This therapeutic action is achieved through the drug's unique nature as a prodrug that becomes activated only inside these susceptible microorganisms. The compound is clinically recognized for its essential use in treating infections where pathogens thrive in environments with low or absent oxygen, establishing Metronidazole as a key compound in these therapeutic niches.
Understanding the Active Substance: Metronidazole's Selectivity
The active substance, Metronidazole, achieves its therapeutic effect through selective antimicrobial action on organisms that thrive in low-oxygen environments. Unlike many traditional antibiotics, the drug's mechanism relies on the target organism's own internal processes to chemically transform the molecule, creating cytotoxic compounds that damage the pathogen's DNA. This distinction, rooted in its nitroimidazole derivative structure, ensures that the drug is preferentially active against the specific anaerobic bacteria and protozoa it is designed to eliminate, confirming its role as a targeted anti-infective agent for both systemic and topical applications.
